colorectal cancer. Malignant neoplasm of rectosigmoid junction
Conditions
Interventions
Intervention 1: Intervention group: In addition to the main cancer treatment regimen, patients will also receive pregabalin chemotherapy at a dose of 75 mg every 12 hours for one month in the first mo
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Colorectal cancer diagnosis Age above 18 years Not using other chemotherapy regimen at the same time
Exclusion criteria
Exclusion criteria: Previous history of neuropathy Diagnosis of polymyositis Renal failure (GFR less than 50) Liver failure (liver enzymes more than 2-3 times normal) Diabetic patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of neuropathy in these patients will be measured. Timepoint: In order to check the duration of neuropathy in these patients, this questionnaire will be completed 3 months and 6 months after the end of treatment. Method of measurement: The amount of neuropathy in these patients will be measured based on a grading scale of 0 to 10. In assessing the severity of painful neuropathy based on this criterion: 0 indicates that the patient has no pain and 10 indicates the most pain that the patient has ever experienced. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoud Aliakbarzadeh
Ghoum University of Medical Sciences
Outcome results
None listed